Anurag Deeconda, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 169 Ashley Ave Rm 202, Charleston, SC 29425 Phone: 803-318-7604 |
Dr. Elizabeth Masindet Perera, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 169 Ashley Ave Rm 202, Charleston, SC 29425 Phone: 843-792-2575 |
Michael Brian Lilly, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 39 Sabin Street, 725 Walton Bldg, Charleston, SC 29425 Phone: 843-792-0592 |
Dr. Lisa Von Moll, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 109 Bee St, Charleston, SC 29403 Phone: 843-789-6013 |
Charles Martin Bunke, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 |
L.w. Preston Church, MD Internal Medicine - Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 |
Leonard S Lichtenstein, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 |
Dr. Ashley Arana Waring, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 30 Courtney Drive Msc 592, Charleston, SC 29425 Phone: 843-792-3355 Fax: 843-876-4809 |
Dr. Charles Spencer Teixeira, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 169 Ashley Avenue, Room 202 Main Hospital Msc 333, Charleston, SC 29425 Phone: 843-792-2575 |
Dominique Bultsma, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 169 Ashley Ave # Msc333, Charleston, SC 29425 Phone: 843-792-2731 |
Diane Leigh Kamen, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 |
Dr. Faye N Hant, D.O. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 96 Jonathan Lucas St, Suite 912 Csb, Charleston, SC 29425 Phone: 843-792-3484 Fax: 843-792-7121 |
Dr. Irl Brian Greenwell, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 |
Dr. Stacy Blecher, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 |
Dr. Rani Shayto, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 169 Ashley Ave, Room 202 Main Hospital, Msc333, Charleston, SC 29425 Phone: 843-792-2911 |
Helen Jensie Burton, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 169 Ashley Avenue, Room 202 Msc333, Charleston, SC 29425 Phone: 843-792-2911 |
Ahmad Aleisa, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 169 Ashley Ave, Room 202 Main Hospital, Charleston, SC 29425 Phone: 843-792-4047 |
Dr. Mitchell Benton, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 169 Ashley Avenue, Room 202 Main Hospital Msc333, Charleston, SC 29425 Phone: 843-792-5386 |
Victoria Davis Delk, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 96 Jonathan Lucas St Rm 807h, Charleston, SC 29425 Phone: 803-315-7669 |
Carlysle Barfield, M.D. Internal Medicine - Rheumatology Medicare: Medicare Enrolled Practice Location: 4 Carriage Ln, Ste. 400e, Charleston, SC 29407 Phone: 843-571-6067 Fax: 843-769-4853 |
News Archive
Researchers have found that several genes within an ancient species of fish can be used to provide clues in the treatment of spinal cord damage. The study titled, "Highly Conserved Molecular Pathways, Including Wnt Signaling, Promote Functional Recovery from Spinal Cord Injury in Lampreys," appeared in the latest issue of the journal Scientific Reports.
In lifesaving procedures to open blocked heart arteries a key question has persisted for years: Is use of the more expensive drug, abciximab, justified over use of the less-expensive eptifibatide
Aradigm Corporation today announced it received clearance from the U.S. Food and Drug Administration (FDA) for its inhaled liposomal ciprofloxacin Investigational New Drug (IND) application. The first trial planned under this IND is a Phase 1/2a, multicenter study designed to evaluate the pharmacokinetics, safety, and tolerability of once-daily administration of 150 mg (3 mL) of Ciprofloxacin for Inhalation (CFI, ARD-3100) in pediatric patients with cystic fibrosis (CF) who have a history of chronic Pseudomonas aeruginosa lung infection.
Some of us can hold our tongues better than others but even the best of us will blurt out the truth when we're tired, stressed or distracted, according to a new research report.
› Verified 4 days ago